Medicure Pharma Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$999,945
Doctors Paid
2,371
Transactions
3,322
2024 Total
$27,667
Payment Breakdown by Category
Research$482,107 (48.2%)
Consulting$196,044 (19.6%)
Food & Beverage$112,144 (11.2%)
Travel$18,242 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $482,107 | 30 | 48.2% |
| Consulting Fee | $196,044 | 327 | 19.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $167,408 | 301 | 16.7% |
| Food and Beverage | $112,144 | 2,644 | 11.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $24,000 | 4 | 2.4% |
| Travel and Lodging | $18,242 | 16 | 1.8% |
Payments by Type
General
$517,839
3,292 transactions
Research
$482,107
30 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM) | $125,000 | 0 | 4 |
| iSPASM | $73,054 | 0 | 1 |
| COMPETE-PCI | $71,461 | 0 | 2 |
| STAIR Registry | $69,075 | 0 | 2 |
| SAVI-PCI | $47,527 | 0 | 11 |
| Substudy of EROSION | $35,075 | 0 | 1 |
| Pediatric Shunts | $23,000 | 1 | 2 |
| Retrospective Neurovascular | $12,500 | 0 | 2 |
| SAVI-PCI Integrilin | $10,363 | 0 | 1 |
| MedStar Meta-Analysis | $6,826 | 0 | 1 |
| Albany Medical Real World Data | $4,000 | 0 | 1 |
| Shear Stress Platelet Activation | $2,226 | 1 | 1 |
| Educational Seminar DMC | $2,000 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 4
| Doctor | Specialty | Location | Total | 2017 |
|---|---|---|---|---|
| Dr. Mauricio Cohen, Md, MD | Cardiovascular Disease | Miami, FL | $1,199 | $0 |
| Tom Lassar, Md, MD | Cardiovascular Disease | Cleveland, OH | $1,182 | $0 |
| Dr. George Kichura, M.d, M.D | Cardiovascular Disease | Saint Louis, MO | $1,177 | $0 |
| Khusrow Niazi, Md, MD | Interventional Cardiology | Atlanta, GA | $1,174 | $0 |
| Dr. Brian O'neill, M.d, M.D | Cardiovascular Disease | Detroit, MI | $1,170 | $0 |
| Dr. Anwar Tandar, Md, MD | Interventional Cardiology | Salt Lake City, UT | $1,167 | $0 |
| Prakash Deedwania, M.d, M.D | Cardiovascular Disease | Fresno, CA | $1,167 | $0 |
| Edo Kaluski, M.d, M.D | Cardiovascular Disease | Sayre, PA | $1,140 | $0 |
| Timothy Henry, Md, MD | Cardiovascular Disease | Cincinnati, OH | $1,135 | $0 |
| Dr. Karim Al-Azizi, M.d, M.D | Interventional Cardiology | Plano, TX | $1,129 | $0 |
| Dr. Peter Jones, M.d, M.D | Internal Medicine | Houston, TX | $1,116 | $0 |
| Unknown Provider | — | — | $1,095 | $0 |
| Dr. Lloyd Klein, Md, MD | Cardiovascular Disease | San Francisco, CA | $1,094 | $0 |
| John Hodgson, M.d, M.D | Cardiovascular Disease | Murray, KY | $1,094 | $0 |
| Dr. Waqas Qureshi, M.d., Mbbs, M.D., MBBS | Cardiovascular Disease | Worcester, MA | $1,080 | $0 |
| Dr. Charles Wilmer, Md, MD | Cardiovascular Disease | Atlanta, GA | $1,080 | $0 |
| Timothy Jayasundera | Cardiovascular Disease | New York, NY | $1,077 | $0 |
| Dr. Arnold Seto, M.d, M.D | Cardiovascular Disease | Orange, CA | $1,077 | $0 |
| Rajesh Swaminathan, M.d, M.D | Internal Medicine | Durham, NC | $1,000 | $0 |
| Dr. Alexander Truesdell, M.d, M.D | Cardiovascular Disease | Falls Church, VA | $1,000 | $0 |
| Michael Wilson, Md, MD | Cardiovascular Disease | Portland, OR | $1,000 | $0 |
| Pedro Villablanca Spinetto, M.d, M.D | Internal Medicine | Detroit, MI | $943.46 | $0 |
| Raed Al-Dallow, M.d, M.D | Cardiovascular Disease | Carbondale, IL | $934.02 | $0 |
| Lior Shamai, D.o, D.O | Internal Medicine | Tulsa, OK | $900.00 | $0 |
| Hady Lichaa, M.d, M.D | Internal Medicine | Murfreesboro, TN | $900.00 | $0 |
Ad
Top Products
- Aggrastat (tirofiban HCl) $619,657
- ZYPITAMAG (pitavastatin) $57,886
Associated Products (12)
- Aggrastat (tirofiban HCl) $619,657
- ZYPITAMAG (pitavastatin) $57,886
- Aggrastat (tirofiban) $51,946
- AGGRASTAT $41,961
- Zypitamag $39,906
- Aggrastat $38,602
- ZYPITAMAG $33,814
- HMG-CoA reductase inhibitor. $30,570
- ReDS $28,081
- HMG-CoA reductase inhibitor $24,450
- Acute cardiovascular care $16,200
- Aggrastat (Tirofiban-HCI) $15,000
Payment Categories
- Food & Beverage $112,144
- Consulting $196,044
- Travel & Lodging $18,242
- Research $482,107
About Medicure Pharma Inc.
Medicure Pharma Inc. has made $999,945 in payments to 2,371 healthcare providers, recorded across 3,322 transactions in the CMS Open Payments database. In 2024, the company paid $27,667. The top product by payment volume is Aggrastat (tirofiban HCl) ($619,657).
Payments were distributed across 71 medical specialties. The top specialty by payment amount is Cardiovascular Disease ($221,475 to 515 doctors).
Payment categories include: Food & Beverage ($112,144), Consulting ($196,044), Research ($482,107), Travel & Lodging ($18,242).
Medicure Pharma Inc. is associated with 12 products in the CMS Open Payments database, including Aggrastat (tirofiban HCl), ZYPITAMAG (pitavastatin), and Aggrastat (tirofiban).